Daymark Wealth Partners LLC lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 8.9% during the fourth quarter, Holdings Channel.com reports. The fund owned 2,813 shares of the company’s stock after purchasing an additional 230 shares during the period. Daymark Wealth Partners LLC’s holdings in HCA Healthcare were worth $844,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of HCA. Benjamin F. Edwards & Company Inc. bought a new position in shares of HCA Healthcare during the 2nd quarter valued at about $33,000. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare in the third quarter valued at $39,000. Canoe Financial LP purchased a new position in HCA Healthcare during the 3rd quarter valued at about $41,000. Capital Performance Advisors LLP purchased a new stake in shares of HCA Healthcare in the third quarter worth approximately $41,000. Finally, Northwest Investment Counselors LLC purchased a new position in HCA Healthcare during the third quarter valued at approximately $44,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.
HCA Healthcare Price Performance
Analysts Set New Price Targets
A number of research firms recently issued reports on HCA. TD Cowen reduced their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. KeyCorp cut their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a research report on Tuesday, December 17th. Oppenheimer increased their target price on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $385.27.
Read Our Latest Analysis on HCA
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Stories
- Five stocks we like better than HCA Healthcare
- Using the MarketBeat Dividend Tax Calculator
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- What Are Dividend Contenders? Investing in Dividend Contenders
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- CD Calculator: Certificate of Deposit Calculator
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.